Cannabis use disorder (CUD) is an underappreciated risk of using cannabis that affects~
10% of the 193 million cannabis users worldwide. The individual and public health burdens …

Oxidative stress, which results in the damage of diverse biological molecules, is a ubiquitous
cellular process implicated in the etiology of many illnesses. The sulfhydryl-containing …

Abstract N-acetyl-L-cysteine (NAC) is a compound of increasing interest in the treatment of
psychiatric disorders. Primarily through its antioxidant, anti-inflammatory, and glutamate …

Cannabis use disorder (CUD) commonly occurs and carries a notable economic and
functional burden at both individual and societal levels. While there are no clearly …

Confusion and controversy related to the potential for cannabis use to cause harm, or
alternatively to provide benefit, continues globally. This issue has grown in intensity and …

Aims This study examined the longitudinal association between reductions in cannabis use
and changes in anxiety, depression, sleep quality, and quality of life. Methods Secondary …

Substance use continues to contribute to significant morbidity and mortality in the United
States, for both women and men, more so than any other preventable health condition. To …

Background The current lack of pharmacological treatments for cannabis use disorder
(CUD) warrants novel approaches and further investigation of promising pharmacotherapy …

N‐acetylcysteine, a sulphur‐containing amino acid for the treatment of paracetamol
overdose and chronic obstructive pulmonary disease, is a widely available off‐the‐shelf oral …

Abstract Purpose of Review To examine the most recent published evidence (2016–2019)
regarding the treatment of adolescent substance use disorders and to provide an update on …